Eurosatory 2012: Thales brings Hawkei to Europe
Thales Australia used the Eurosatory exhibition in Paris on 11 June to display its Hawkei light protected vehicle in Europe for the first time.
Developed for an Australian Defence Force (ADF) requirement for 1,300 new vehicles to replace its current Land Rover fleet, the 7 tonne Hawkei is designed to be easily deployable but still providing high levels of protection.
Chris Jenkins, Thales Australia’s CEO, told reporters that in delivering six Hawkei prototypes as part of Australia’s LAND 121 phase 4 programme, the company was providing a tactical vehicle with the same protection levels of the Bushmaster protected mobility vehicle.
Already have an account? Log in
Want to keep reading this article?
Read this Article
Get access to this article with a Free Basic Account
- Original curated content, daily across air, land and naval domains
- 2 free stories per week
- Daily news round-up email service
- Access to all Decisive Edge email newsletters
Unlimited Access
Access to all our premium news as a Premium News 365 Member. Corporate subscriptions available.
- Original curated content, daily across air, land and naval domains
- 14-day free trial (cancel at any time)
- Unlimited access to all published premium news
More from Land Warfare
-
![Lockheed Martin to increase PAC-3 MSE production by 70%]()
Lockheed Martin to increase PAC-3 MSE production by 70%
The company manufactured 380 missiles in 2023 and plans to build 650 missiles per year from 2027.
-
![Latvia orders more Patria 6x6 vehicles]()
Latvia orders more Patria 6x6 vehicles
The first Latvian-made Common Armoured Vehicle System (CAVS) 6x6 armoured personnel carrier was delivered to the Latvian National Armed Forces (NAF) in August, and more than 200 vehicles are expected to be delivered by 2029.
-
![Canadian tech firm makes promise to increase precision and longevity of weapons]()
Canadian tech firm makes promise to increase precision and longevity of weapons
Supplied by Paradigm Shift, EPVD technology has undergone trials with the US and Canadian services.
